122 related articles for article (PubMed ID: 29781127)
1. Removal Dynamics of Autoantibodies, Immunoglobulins, and Coagulation Factors by Selective Plasma Exchange on Three Consecutive Days.
Miyamoto S; Ohkubo A; Seshima H; Yamamoto H; Itagaki A; Maeda T; Kurashima N; Mori T; Iimori S; Naito S; Sohara E; Rai T; Uchida S; Okado T
Ther Apher Dial; 2018 Jun; 22(3):255-260. PubMed ID: 29781127
[TBL] [Abstract][Full Text] [Related]
2. Selective Plasma Exchange for the Removal of Pemphigus Autoantibodies, Fibrinogen, and Factor XIII in Pemphigus Vulgaris.
Miyamoto S; Ohkubo A; Seshima H; Komori S; Yamamoto M; Maeda T; Itagaki A; Yamamoto H; Nojima K; Iimori S; Naito S; Kurashima N; Sohara E; Rai T; Uchida S; Okado T
Ther Apher Dial; 2017 Jun; 21(3):226-231. PubMed ID: 28661086
[TBL] [Abstract][Full Text] [Related]
3. Removal Dynamics of Immunoglobulin and Fibrinogen by Conventional Plasma Exchange, Selective Plasma Exchange, and a Combination of the Two.
Miyamoto S; Ohkubo A; Seshima H; Maeda T; Itagaki A; Kurashima N; Iimori S; Naito S; Sohara E; Rai T; Uchida S; Okado T
Ther Apher Dial; 2016 Aug; 20(4):342-7. PubMed ID: 27523073
[TBL] [Abstract][Full Text] [Related]
4. Selective plasma exchange.
Ohkubo A; Okado T
Transfus Apher Sci; 2017 Oct; 56(5):657-660. PubMed ID: 28939369
[TBL] [Abstract][Full Text] [Related]
5. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
Guptill JT; Juel VC; Massey JM; Anderson AC; Chopra M; Yi JS; Esfandiari E; Buchanan T; Smith B; Atherfold P; Jones E; Howard JF
Autoimmunity; 2016 Nov; 49(7):472-479. PubMed ID: 27684107
[TBL] [Abstract][Full Text] [Related]
6. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
[TBL] [Abstract][Full Text] [Related]
7. Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
Nasu K; Hanafusa N; Nangaku M
J Clin Apher; 2017 Dec; 32(6):589-591. PubMed ID: 27709645
[TBL] [Abstract][Full Text] [Related]
8. Removal Characteristics of Immunoglobulin G Subclasses by Conventional Plasma Exchange and Selective Plasma Exchange.
Ohkubo A; Okado T; Kurashima N; Maeda T; Arai S; Miyamoto S; Itagaki A; Seshima H; Iimori S; Naito S; Sohara E; Uchida S; Rai T
Ther Apher Dial; 2015 Aug; 19(4):361-6. PubMed ID: 26386225
[TBL] [Abstract][Full Text] [Related]
9. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
Tagawa Y; Yuki N; Hirata K
J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
[TBL] [Abstract][Full Text] [Related]
10. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Substance Removal by Immunoadsorption With a Selective Plasma Separator.
Hanafusa N; Yamamoto H; Tamachi M; Torato T; Sakurai S; Tsuchiya K; Nitta K; Nangaku M
Ther Apher Dial; 2017 Jun; 21(3):218-225. PubMed ID: 28661087
[TBL] [Abstract][Full Text] [Related]
12. Clearance efficacy of autoantibodies in double filtration plasmapheresis for pemphigus foliaceus.
Kasuya A; Moriki M; Tatsuno K; Hirakawa S; Tokura Y
Acta Derm Venereol; 2013 Mar; 93(2):181-2. PubMed ID: 22948906
[No Abstract] [Full Text] [Related]
13. Differences in reduction of coagulation factor XIII (F13) between immunoadsorption plasmapheresis and double filtration plasmapheresis.
Hanafusa N; Noiri E; Nangaku M
Ther Apher Dial; 2013 Apr; 17(2):241-2. PubMed ID: 23551681
[No Abstract] [Full Text] [Related]
14. Fibrinogen Reduction During Selective Plasma Exchange due to Membrane Fouling.
Ohkubo A; Okado T; Miyamoto S; Hashimoto Y; Komori S; Yamamoto M; Maeda T; Itagaki A; Yamamoto H; Seshima H; Kurashima N; Iimori S; Naito S; Sohara E; Uchida S; Rai T
Ther Apher Dial; 2017 Jun; 21(3):232-237. PubMed ID: 28661096
[TBL] [Abstract][Full Text] [Related]
15. The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels.
Wood L; Jacobs P
J Clin Apher; 1986; 3(2):124-8. PubMed ID: 3516979
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies and immunoglobulins among atomic bomb survivors.
Fujiwara S; Carter RL; Akiyama M; Akahoshi M; Kodama K; Shimaoka K; Yamakido M
Radiat Res; 1994 Jan; 137(1):89-95. PubMed ID: 8265792
[TBL] [Abstract][Full Text] [Related]
17. Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders.
Ohkubo A; Okado T; Kurashima N; Maeda T; Miyamoto S; Nakamura A; Seshima H; Iimori S; Sohara E; Uchida S; Rai T
Ther Apher Dial; 2014 Jun; 18(3):231-7. PubMed ID: 24965288
[TBL] [Abstract][Full Text] [Related]
18. Intensive plasma exchange--effects on haemostasis.
Urbaniak SJ
Prog Clin Biol Res; 1982; 108():191-212. PubMed ID: 7178147
[TBL] [Abstract][Full Text] [Related]
19. [Plasmapheresis for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Odaka M
Nihon Rinsho; 2004 May; 62 Suppl 5():491-5. PubMed ID: 15197970
[No Abstract] [Full Text] [Related]
20. Plasma exchange in systemic lupus erythematosus. Experience in thirty-seven patients.
Lombardo R; Cepparrone F; Di Pietro G; Franco C; Graziani G; Avanzi G
Int J Artif Organs; 1993 Dec; 16 Suppl 5():177-9. PubMed ID: 8013982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
